MS, COVID-19 and vaccines – updated global advice

Advice for people with MS - updated on 21 March

An update from the MS Global Data Sharing Initiative – Thank You!

When we come together, we can find answers, quickly, to global MS challenges.

How do people with MS respond to COVID-19 vaccines?

What does research tell us about how DMTs affect the body’s immune response to COVID-19 vaccines?

The power of translation: making MS information accessible

Discover how MS organisations collaborate to translate vital MS information.

How £513,000 is supporting 21 MS organisations through the pandemic

Six months into the COVID-19 Response Initiative

How do different DMTs affect people’s COVID-19 vaccine response?

Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.

MSIF grants £500,000 to MS organisations through the COVID-19 Response Initiative

MSIF grants over £500,000 to MS organisations to help them through the pandemic.

Could the science behind a vaccine be used to treat MS?

Could a vaccine treat MS?

Ten months in: the COVID-19 and MS global data sharing initiative

A look back at what the global MS movement has achieved during the pandemic.

Thank you masks from Brazil

The COVID-19 pandemic has brought unprecedented challenges to MS organisations across the world, and the Associação Brasileira de Esclerose Múltipla (ABEM) in Brazil is no exception.

Responding to the data: new global COVID-19 advice for people with MS

Updated global advice for people with MS and the data behind it

MS research awards: deadline extended to 31 August

Finding the answers to COVID-19 & MS : Your role in the global effort

Register now: a webinar for people with MS and MS organisations – your questions answered on the COVID-19 & MS global data sharing initiative

MS data sharing during the coronavirus pandemic

Sharing data to find answers quicker during COVID-19

A message of global solidarity during COVID-19

A message from the CEO of the MS International Federation as the global MS community faces the challenges of the coronavirus